abstract |
Provided herein are methods and compositions for treating a subject having cancer by administering to the subject a neoantigen-based vaccine composition and a long acting, IL-2RPĪ²-selective agonist composition comprised of compounds of Formula (I), and optionally, an anti-PD-1 antibody. |